Prenatal diagnosis of congenital lipoid adrenal hyperplasia Article

Saenger, P, Klonari, Z, Fleischer, A et al. (1995). Prenatal diagnosis of congenital lipoid adrenal hyperplasia . 80(1), 200-205. 10.1210/jcem.80.1.7829612

cited authors

  • Saenger, P; Klonari, Z; Fleischer, A; Abram, CAL; Compagnone, N; Mellon, SH; Black, SM; Miller, WL; Shackelton, CHL

fiu authors


  • Congenital lipoid adrenal hyperplasia (lipoid CAH) is a rare genetic disorder of adrenal and gonadal steroidogenesis of unknown cause in which cholesterol cannot be converted to pregnenolone. As a result, affected individuals can make no steroid hormones, so that all affected newborns are phenotypic females, irrespective of karyotype. We studied two pregnancies in a family with two previously affected children by examining fetal karyotype, genital ultrasonography, and amniotic fluid steroid concentrations and by performing ACTH tests on family members. Prenatal diagnosis correctly identified both an unaffected XX fetus and an affected XY fetus. In the affected pregnancy, amniotic fluid concentrations of progesterone and pregnenolone were 30% and 50% of normal, respectively, but concentrations of 17 alpha-hydroxypregnenolone, 17 α-hydroxyprogesterone, cortisol, dehydroepiandrosterone, androstenedione, and estriol were either extremely low or undetectable, suggesting that these detected steroids were donated by maternal steroidogenesis. Fetal cord blood obtained at the termination of pregnancy showed very low concentrations of estrogens donated by the mother’s circulation. Absent fetal steroidogenesis was confirmed by gas chromatography and mass spectrometry of both fetal and maternal serum. The responses of 10 different steroids to adrenal stimulation with ACTH in the obligately heterozygous parents were normal. Thus, unlike the case with other forms of CAH, heterozygosity cannot be determined by hormonal responses to provocative testing with ACTH. Immunocytochemistry and Western blotting showed that the affected placental tissue contained P450scc protein, confirming that P450scc is intact in these patients. © 1995 by The Endocrine Society.

publication date

  • January 1, 1995

Digital Object Identifier (DOI)

start page

  • 200

end page

  • 205


  • 80


  • 1